secwatch.observer — SEC 8-K summary
======================================

Issuer:     RetinalGenix Technologies Inc. (RTGN)
CIK:        0001836295
Form:       8-K
Filed at:   2022-07-28T23:59:59+00:00
Accession:  0001493152-22-020481
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

RetinalGenix appoints Vinay Mehindru, MD, MBA to board of directors
-------------------------------------------------------------------

- Vinay Mehindru, age 55, appointed director effective July 25, 2022.
- He has over 25 years of healthcare experience; currently CEO of Exemplary Health.
- Previously President of AdventHealth's clinically integrated networks (2014-2019) and CMO.
- No family relationships or material interests with company directors or officers.
- Appointment fills board seat; no departure of existing directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1836295/000149315222020481/0001493152-22-020481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1836295/000149315222020481/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-020481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer